BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 26758946)

  • 1. Basic and Clinical Observations of Mevalonate Depletion on the Mevalonate Signaling Pathway.
    Muller AL; Freed DH
    Curr Mol Pharmacol; 2017; 10(1):6-12. PubMed ID: 26758946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mevalonate Cascade and its Regulation in Cholesterol Metabolism in Different Tissues in Health and Disease.
    Hashemi M; Hoshyar R; Ande SR; Chen QM; Solomon C; Zuse A; Naderi M
    Curr Mol Pharmacol; 2017; 10(1):13-26. PubMed ID: 26758949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Mevalonate Pathway and Innate Immune Hyper-Responsiveness in the Pathogenesis of COPD and Lung Cancer: Potential for Chemoprevention.
    Young RP; Hopkins RJ
    Curr Mol Pharmacol; 2017; 10(1):46-59. PubMed ID: 26758944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulatory effects of HMG-CoA reductase inhibitors in diabetic microangiopathy.
    Danesh FR; Kanwar YS
    FASEB J; 2004 May; 18(7):805-15. PubMed ID: 15117885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interconnection of Estrogen/Testosterone Metabolism and Mevalonate Pathway in Breast and Prostate Cancers.
    Mokarram P; Alizadeh J; Razban V; Barazeh M; Solomon C; Kavousipour S
    Curr Mol Pharmacol; 2017; 10(2):86-114. PubMed ID: 26758947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mevalonate Pathway Blockade, Mitochondrial Dysfunction and Autophagy: A Possible Link.
    Tricarico PM; Crovella S; Celsi F
    Int J Mol Sci; 2015 Jul; 16(7):16067-84. PubMed ID: 26184189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mevalonate Cascade and Neurodevelopmental and Neurodegenerative Diseases: Future Targets for Therapeutic Application.
    Jiao X; Ashtari N; Rahimi-Balaei M; Chen QM; Badbezanchi I; Shojaei S; Marzban A; Mirzaei N; Chung S; Guan T; Li J; Vriend J; Mehr SE; Kong J; Marzban H
    Curr Mol Pharmacol; 2017; 10(2):115-140. PubMed ID: 26758948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-transcriptional regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase by mevalonate.
    Straka MS; Panini SR
    Arch Biochem Biophys; 1995 Feb; 317(1):235-43. PubMed ID: 7872789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coenzyme Q10 and statin-related myopathy.
    Drug Ther Bull; 2015 May; 53(5):54-6. PubMed ID: 25977402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial respiratory chain dysfunction alters ER sterol sensing and mevalonate pathway activity.
    Wall CTJ; Lefebvre G; Metairon S; Descombes P; Wiederkehr A; Santo-Domingo J
    J Biol Chem; 2022 Mar; 298(3):101652. PubMed ID: 35101444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease.
    Yeganeh B; Wiechec E; Ande SR; Sharma P; Moghadam AR; Post M; Freed DH; Hashemi M; Shojaei S; Zeki AA; Ghavami S
    Pharmacol Ther; 2014 Jul; 143(1):87-110. PubMed ID: 24582968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the class II HMG-CoA reductase of Pseudomonas mevalonii.
    Hedl M; Rodwell VW
    Protein Sci; 2004 Jun; 13(6):1693-7. PubMed ID: 15152097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the Mevalonate Pathway for Treating Esophageal Cancer.
    Wong JVS; Fatehi Hassanabad A
    J Gastrointest Cancer; 2021 Jun; 52(2):819-821. PubMed ID: 33931828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HMG-CoA reductase inhibition causes neurite loss by interfering with geranylgeranylpyrophosphate synthesis.
    Schulz JG; Bösel J; Stoeckel M; Megow D; Dirnagl U; Endres M
    J Neurochem; 2004 Apr; 89(1):24-32. PubMed ID: 15030386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plant-derived monoterpenes suppress hamster kidney cell 3-hydroxy-3-methylglutaryl coenzyme a reductase synthesis at the post-transcriptional level.
    Peffley DM; Gayen AK
    J Nutr; 2003 Jan; 133(1):38-44. PubMed ID: 12514264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol inhibits the mevalonate pathway and potentiates the antiproliferative effects of simvastatin in rat theca-interstitial cells.
    Wong DH; Villanueva JA; Cress AB; Sokalska A; Ortega I; Duleba AJ
    Fertil Steril; 2011 Nov; 96(5):1252-8. PubMed ID: 21907337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mevalonate signaling, COPD and cancer: the statins and beyond.
    Hopkins RJ; Young RP
    J Investig Med; 2019 Apr; 67(4):711-714. PubMed ID: 30787037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo anti-inflammatory effect of statins is mediated by nonsterol mevalonate products.
    Diomede L; Albani D; Sottocorno M; Donati MB; Bianchi M; Fruscella P; Salmona M
    Arterioscler Thromb Vasc Biol; 2001 Aug; 21(8):1327-32. PubMed ID: 11498461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mevalonate Cascade and Small Rho GTPase in Spinal Cord Injury.
    Eftekharpour E; Nagakannan P; Iqbal MA; Chen QM
    Curr Mol Pharmacol; 2017; 10(2):141-151. PubMed ID: 26758952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Could drugs inhibiting the mevalonate pathway also target cancer stem cells?
    Likus W; Siemianowicz K; Bieńk K; Pakuła M; Pathak H; Dutta C; Wang Q; Shojaei S; Assaraf YG; Ghavami S; Cieślar-Pobuda A; Łos MJ
    Drug Resist Updat; 2016 Mar; 25():13-25. PubMed ID: 27155373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.